Your browser doesn't support javascript.
loading
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy.
Kutlu, Yasin; Aydin, Sabin Goktas; Bilici, Ahmet; Oven, Bala Basak; Olmez, Omer Fatih; Acikgoz, Ozgur; Hamdard, Jamshid.
Afiliação
  • Kutlu Y; Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey.
  • Aydin SG; Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey.
  • Bilici A; Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey.
  • Oven BB; Department of Medical Oncology, Yeditepe University Faculty of Medicine, Istanbul, Turkey.
  • Olmez OF; Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey.
  • Acikgoz O; Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey.
  • Hamdard J; Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey.
Medicine (Baltimore) ; 102(15): e33432, 2023 Apr 14.
Article em En | MEDLINE | ID: mdl-37058061

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article